Find trials
Search tips

Understanding CVUE in the Placenta

Overview

About this study

The purpose of this study is to measure chronic villitis of unknown etiology (CVUE) induced changes in cellular interactions at the maternal fetal interface and define the antigen specific T cell mechanisms driving CVUE.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Pregnant adults.
  • ≥ 18 years of age.
  • Singleton pregnancy.
  • Clinically being seen by Mayo physicians.
  • Willing and able to provide consent.
  • Delivering at Mayo Clinic Rochester, MN.

Exclusion Criteria: 

  •  < 18 years of age.
  • Cannot provide consent.
  • Not planning to deliver in Rochester.
  • Multiple fetuses.
  • Fetal growth restriction associated with genetic anomalies, congenital infection, and/or maternal chronic hypertension.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 1/2/24. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Elizabeth Ann Enninga, Ph.D.

Open for enrollment

Contact information:

Elizabeth Ann Enninga Ph.D.

(507) 538-7615

Enninga.ElizabethAnn@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20567917

Mayo Clinic Footer